NCT07407153 Triaging of Women Detected With a Breast Lump on Clinical Breast Examination Using Portable Ultrasound Device
| NCT ID | NCT07407153 |
| Status | Recruiting |
| Phase | — |
| Sponsor | International Agency for Research on Cancer |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2028-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2025-06-01 with a primary completion date of 2028-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to stratify women diagnosed with a lump in the breast by clinical breast examination(CBE) using a hand-held ultrasound machine. They will be stratified either with benign or potentially malignant lesion. As most of the lesions identified by CBE are benign, stratifying them (triage) avoids the unnecessary procedures in terms of mammography and biopsy. This will also reduce the burden in the further assessment sites, and provide better quality services in these places.
Eligibility Criteria
Inclusion Criteria: * Women eligible for breast cancer screening as per the National screening programme in the country, and those detected with a breast lump on clinical breast examination Exclusion Criteria: * Women already screened in the last three years * Women with known history of breast cancer or breast surgery * Symptomatic with high probability of breast cancer diagnosis (ulcerated lump, blood-stained nipple discharge etc.) * Debilitating illness * Unable to provide informed consent due to certain mental illnesses * Unlikely to be compliant to study procedures and/or follow up as determined by the investigator
Frequently Asked Questions
Who can join the NCT07407153 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 69 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07407153 currently recruiting?
Yes, NCT07407153 is actively recruiting participants. Visit ClinicalTrials.gov or contact International Agency for Research on Cancer to inquire about joining.
Where is the NCT07407153 trial being conducted?
This trial is being conducted at Jakarta, Indonesia.
Who is sponsoring the NCT07407153 clinical trial?
NCT07407153 is sponsored by International Agency for Research on Cancer. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.